Eterno et al., showed that the protein AurkA can regulate the Wnt3a ligand levels by inhibiting mir-128 and thus regulating the stem cell phenotype in breast cancer (Eterno et al., 2016). The gene discussed is AURKA; the disease is breast carcinoma.